Automate Your Wheel Strategy on INFU
With Tiblio's Option Bot, you can configure your own wheel strategy including INFU - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol INFU
- Rev/Share 6.5128
- Book/Share 2.6106
- PB 2.1451
- Debt/Equity 0.6014
- CurrentRatio 2.2119
- ROIC 0.1001
- MktCap 117461680.0
- FreeCF/Share 0.7689
- PFCF 7.232
- PE 27.9669
- Debt/Assets 0.318
- DivYield 0
- ROE 0.0763
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 3
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | INFU | Roth Capital | -- | Buy | -- | $12 | July 22, 2025 |
| Initiation | INFU | B. Riley Securities | -- | Buy | -- | $13 | Sept. 26, 2024 |
News
Is the Options Market Predicting a Spike in InfuSystems Holdings Stock?
INFU
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to InfuSystems Holdings stock based on the movements in the options market lately.
Read More
InfuSystems Holdings, Inc. (INFU) Reports Q1 Loss, Tops Revenue Estimates
INFU
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Negative
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Negative
InfuSystems Holdings, Inc. (INFU) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.05 per share a year ago.
Read More
InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025
INFU
Published: May 01, 2025 by: Business Wire
Sentiment: Neutral
Published: May 01, 2025 by: Business Wire
Sentiment: Neutral
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025.
Read More
About InfuSystem Holdings, Inc. (INFU)
- IPO Date 2007-12-27
- Website https://www.infusystem.com
- Industry Medical - Instruments & Supplies
- CEO Richard Armand DiIorio
- Employees 502
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.